Medarex is seeking targets
Medarex business development
Medarex is a biopharmaceutical company focused on the discovery, development, and potential commercialization of fully human antibody-based therapeutics to treat life- threatening and debilitating diseases, including cancer, inflammation, autoimmune and infectious diseases.
They continue to increase their access to novel therapeutic targets by establishing collaborations with other companies and institutions that have identified potential therapeutic targets or have created platforms for the identification of such targets.
Medarex believes that combining the abundance of new disease targets with the breadth of their human antibody technology provides an opportunity to develop far more products than any one company can accommodate. Therefore, they have adopted a strategy of sharing in the success of many companies as they employ their UltiMAb Antibody Development System to create antibody-based products, while at the same time building their own broad product pipeline.
They actively seek opportunities to in-license and/or acquire such targets and intend to develop novel therapeutic products by producing fully human antibodies that interact with such targets.